Stockreport

Generic Revlimid Could Sink Celgene [Seeking Alpha]

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
PDF Generic Revlimid Could Sink CelgeneSummaryMYL and Dr. Reddy's are pushing to offer generic Revlimid.Revlimid represents over 60% of CELG's revenue and is responsible for [Read more]